Ann‐Cathrine Jönsson‐Rylander

1.5k total citations
26 papers, 911 citations indexed

About

Ann‐Cathrine Jönsson‐Rylander is a scholar working on Molecular Biology, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ann‐Cathrine Jönsson‐Rylander has authored 26 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Surgery and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ann‐Cathrine Jönsson‐Rylander's work include Pancreatic function and diabetes (6 papers), Neuropeptides and Animal Physiology (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Ann‐Cathrine Jönsson‐Rylander is often cited by papers focused on Pancreatic function and diabetes (6 papers), Neuropeptides and Animal Physiology (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Ann‐Cathrine Jönsson‐Rylander collaborates with scholars based in Sweden, United Kingdom and Netherlands. Ann‐Cathrine Jönsson‐Rylander's co-authors include Birgitta Rosengren, Eva Hurt‐Camejo, Margareta Behrendt, Margareta Nordlander, H. Peilot, Susanne Nyström, Renhai Cao, Hessameh Hassani, Yihai Cao and A. Jonas Ekstrand and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The FASEB Journal.

In The Last Decade

Ann‐Cathrine Jönsson‐Rylander

26 papers receiving 897 citations

Peers

Countries citing papers authored by Ann‐Cathrine Jönsson‐Rylander

Since Specialization

Citations

This map shows the geographic impact of Ann‐Cathrine Jönsson‐Rylander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Cathrine Jönsson‐Rylander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Cathrine Jönsson‐Rylander more than expected).

Fields of papers citing papers by Ann‐Cathrine Jönsson‐Rylander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann‐Cathrine Jönsson‐Rylander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Cathrine Jönsson‐Rylander. The network helps show where Ann‐Cathrine Jönsson‐Rylander may publish in the future.

Co-authorship network of co-authors of Ann‐Cathrine Jönsson‐Rylander

This figure shows the co-authorship network connecting the top 25 collaborators of Ann‐Cathrine Jönsson‐Rylander. A scholar is included among the top collaborators of Ann‐Cathrine Jönsson‐Rylander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann‐Cathrine Jönsson‐Rylander. Ann‐Cathrine Jönsson‐Rylander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The APOE∗3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis 2019 ·Journal of Diabetes Research ·Marianne Pouwer, Suvi E. Heinonen, Margareta Behrendt, Anne‐Christine Andréasson, Arianne van Koppen, Aswin Menke, Elsbet Pieterman, Anita M. van den Hoek, J. Wouter Jukema, Brendan Leighton, Ann‐Cathrine Jönsson‐Rylander, P. Hans	9
2	l‐α‐Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK‐dependent pathway 2019 ·Pharmacology Research & Perspectives ·(unknown), Sarah K. Walsh, Erik Ryberg, Ann‐Cathrine Jönsson‐Rylander, Christopher Lipina, Cherry L. Wainwright	34
3	SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice 2019 ·Cardiovascular Diabetology ·Damilola D. Adingupu, Sven Göpel, Julia Grönros, Margareta Behrendt, Matúš Soták, Tasso Miliotis, (unknown), Li‐Ming Gan, Ann‐Cathrine Jönsson‐Rylander	126
4	In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR^–/–ApoB^100/100 mice 2018 ·Diabetes and Vascular Disease Research ·(unknown), Suvi E. Heinonen, Erika Gurzeler, Lisa M. Berglund, (unknown), Olga Kotova, Ann‐Cathrine Jönsson‐Rylander, Seppo Ylä‐Herttuala, Maria F. Gomez	3
5	Radial artery intima-media thickness regresses after secondary prevention interventions in patients’ post-acute coronary syndrome and is associated with cardiac and kidney biomarkers 2017 ·Oncotarget ·Damilola D. Adingupu, (unknown), Santosh Dahgam, Ann‐Cathrine Jönsson‐Rylander, Juuso Blomster, Per Albertsson, Elmir Ömerovic, Sara Svedlund, Li‐Ming Gan	2
6	Impaired Coronary and Renal Vascular Function in Spontaneously Type 2 Diabetic Leptin-Deficient Mice 2015 ·PLoS ONE ·(unknown), Julia Grönros, Suvi E. Heinonen, Tasso Miliotis, Karin Jennbacken, Alan Sabirsh, Anette Ericsson, Ann‐Cathrine Jönsson‐Rylander, Sara Svedlund, Li‐Ming Gan	21
7	GPR55 Deletion in Mice Leads to Age-Related Ventricular Dysfunction and Impaired Adrenoceptor-Mediated Inotropic Responses 2014 ·PLoS ONE ·Sarah K. Walsh, (unknown), Anne‐Christine Andréasson, Ann‐Cathrine Jönsson‐Rylander, Cherry L. Wainwright	22
8	Diabetes complications in congenic leptin receptor deficient BBDR.cg‐lepr.cp rats (1072.6) 2014 ·The FASEB Journal ·Lisa Berglund, (unknown), (unknown), Anna V. Zetterqvist, Olga Kotova, (unknown), Martin Johansson, Nils Wierup, Ann‐Cathrine Jönsson‐Rylander, Åke Lernmark, Maria F. Gomez	2
9	The role of GABA_Areceptors in the control of transient lower oesophageal sphincter relaxations in the dog 2008 ·British Journal of Pharmacology ·Hanneke Beaumont, Ann‐Cathrine Jönsson‐Rylander, (unknown), Stefan Pierrou, (unknown), Lena Brändén, J Jensen, Guy E. Boeckxstaens, A. Lehmann	10
10	Role of secretory phospholipases in atherogenesis 2008 ·Current Atherosclerosis Reports ·Ann‐Cathrine Jönsson‐Rylander, (unknown), Birgitta Rosengren, (unknown), Eva Hurt‐Camejo	29
11	Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis 2006 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Birgitta Rosengren, Ann‐Cathrine Jönsson‐Rylander, H. Peilot, Germán Camejo, Eva Hurt‐Camejo	45
12	Secretory Phospholipase A₂Group V 2006 ·Arteriosclerosis Thrombosis and Vascular Biology ·Birgitta Rosengren, H. Peilot, (unknown), Ann‐Cathrine Jönsson‐Rylander, Lillemor Mattsson-Hultén, Carina Hallberg, Philippe Cronet, Mariam Rodrı́guez-Lee, Eva Hurt‐Camejo	78
13	Fourth meeting of the European Network of Research Tissue Banks – Future strategy to increase collaborations in the supply of human tissue for biomedical research 2005 ·Cell and Tissue Banking ·Samantha Orr, (unknown), (unknown), Neil Gray, (unknown), Rivka Ravid, (unknown), (unknown), (unknown), Ann‐Cathrine Jönsson‐Rylander, (unknown), Tambet Teesalu, Wolfgang E. Thasler, (unknown), Jan van der Valk, Thomas S. Weiß, Chris Womack, Timo Ylikomi	6
14	Chronic Stress Induces Rapid Occlusion of Angioplasty-Injured Rat Carotid Artery by Activating Neuropeptide Y and Its Y1 Receptors 2005 ·Arteriosclerosis Thrombosis and Vascular Biology ·Lijun Li, Ann‐Cathrine Jönsson‐Rylander, Ken Abe, Zofia Żukowska	40
15	Role of ADAMTS-1 in Atherosclerosis 2004 ·Arteriosclerosis Thrombosis and Vascular Biology ·Ann‐Cathrine Jönsson‐Rylander, Tina Nilsson, Regina Fritsche‐Danielson, (unknown), Margareta Behrendt, Jan-Olof Andersson, Kerstin Lindgren, (unknown), Pia Wallbrandt, Birgitta Rosengren, Peter Brodin, Anders Thelin, (unknown), Eva Hurt‐Camejo, (unknown)	145
16	Distribution of neuropeptide Y Y1 and Y2 receptors in the postmortem human heart 2003 ·Peptides ·Ann‐Cathrine Jönsson‐Rylander, Margareta Nordlander, Aud Svindland, Arnfinn Ilebekk	23
17	Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing 2003 ·Proceedings of the National Academy of Sciences ·A. Jonas Ekstrand, Renhai Cao, Meit A. Björndahl, Susanne Nyström, Ann‐Cathrine Jönsson‐Rylander, Hessameh Hassani, (unknown), Margareta Nordlander, Yihai Cao	154
18	Effect of Acid Perfusion on Passive Electrophysiological Properties of Rabbit Esophagus In Vivo 2002 ·Digestive Diseases and Sciences ·Ingemar Jacobson, (unknown), Ann‐Cathrine Jönsson‐Rylander, Roy C. Orlando	7
19	Characterization of the Cloned Atlantic Cod Neuropeptide Y-Yb Receptor: Peptide-Binding Requirements Distinct from Known Mammalian Y Receptors 1999 ·General and Comparative Endocrinology ·Parul Sharma, Ann‐Kristin Arvidsson, Amanda Wraith, Annette G. Beck‐Sickinger, Ann‐Cathrine Jönsson‐Rylander, Dan Larhammar	11
20	Cloning of a neuropeptide Y/peptide YY receptor from the atlantic cod: the Yb receptor 1998 ·Regulatory Peptides ·Ann‐Kristin Arvidsson, Amanda Wraith, Ann‐Cathrine Jönsson‐Rylander, Dan Larhammar	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact